Wolverine Asset Management LLC Intercept Pharmaceuticals, Inc. Call Options Transaction History

Wolverine Asset Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2021 May 13, 2021	SELL	$19.33 - $37.75 $25,128 - $49,075	-1,300 Reduced 72.22%	500 $11,000
Q4 2020 Feb 12, 2021	SELL	$24.48 - $42.47 $2,448 - $4,247	-100 Reduced 5.26%	1,800 $44,000
Q3 2020 Nov 13, 2020	BUY	$39.09 - $53.44 $3,909 - $5,344	100 Added 5.56%	1,900 $78,000
Q2 2020 Aug 13, 2020	SELL	$46.7 - $92.04 $9,340 - $18,408	-200 Reduced 10.0%	1,800 $86,000
Q1 2020 May 13, 2020	BUY	$48.35 - $118.68 $96,700 - $237,360	2,000 New	2,000 $125,000

Q1 2018 May 15, 2018	SELL	$52.72 - $67.25 $21,088 - $26,900	-400 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$57.01 - $118.75 $22,804 - $47,500	400	400 $23,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Wolverine Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Asset Management LLC with notifications on news.